Department of Internal Medicine, Caen University Hospital, Caen, France.
Department of Immunology, Caen University Hospital, Caen, France; Caen University-Normandie, Caen, France.
Autoimmun Rev. 2020 Sep;19(9):102612. doi: 10.1016/j.autrev.2020.102612. Epub 2020 Jul 12.
"Rhupus" or "rhupus syndrome" is a poorly described and underdiagnosed disease in which features of both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) appear in the same patient, most often sequentially. The SLE-related involvement is usually mild, dominated by hematological abnormalities and skin, serosal and renal involvement. The natural history of rhupus arthritis follows an RA-like pattern and can progress towards typical inflammatory erosions, deformations and disability. Despite the lack of consensus on the definition of rhupus and on its place in the spectrum of autoimmunity, a growing number of studies are pointing towards a true overlap between RA and SLE. However, the inclusion criteria employed in the literature during the last 4 decades are heterogeneous, making the already rare cohorts and case reports difficult to analyze. Because of this heterogeneity and due to the rarity of the disease, the prevalence, pathophysiology and natural history as well as the radiological and immunological profiles of rhupus are poorly described. Moreover, since there is no validated therapeutic strategy, treatment is based on clinicians' experience and on the results of a few studies. We herein present a systematic literature review to analyze the clinical and laboratory data of all reported rhupus patients and to provide up-to-date information about recent advances in the understanding of the pathophysiological mechanisms, diagnostic tools and treatment options.
“类风湿红斑”或“类风湿红斑综合征”是一种描述不佳且诊断不足的疾病,其特征是同一患者同时出现类风湿关节炎(RA)和系统性红斑狼疮(SLE)的表现,通常是先后出现。SLE 相关的表现通常较为轻微,主要表现为血液学异常以及皮肤、浆膜和肾脏受累。类风湿红斑关节炎的自然病程呈 RA 样模式,并可进展为典型的炎症性侵蚀、畸形和残疾。尽管对于类风湿红斑的定义及其在自身免疫谱中的位置尚未达成共识,但越来越多的研究表明 RA 和 SLE 之间确实存在重叠。然而,在过去 40 年的文献中,纳入标准存在异质性,使得本就罕见的队列和病例报告难以分析。由于这种异质性以及疾病的罕见性,类风湿红斑的患病率、发病机制和自然病史以及放射学和免疫学特征描述不佳。此外,由于缺乏经过验证的治疗策略,治疗主要基于临床医生的经验以及少数研究的结果。我们在此进行了系统的文献回顾,以分析所有报告的类风湿红斑患者的临床和实验室数据,并提供有关该疾病在发病机制、诊断工具和治疗选择方面的最新进展的信息。